Skip to main content
. Author manuscript; available in PMC: 2024 Jan 26.
Published in final edited form as: J Med Chem. 2023 Jan 11;66(2):1484–1508. doi: 10.1021/acs.jmedchem.2c01651

Figure 1.

Figure 1.

a) Representative Pf20S inhibitors. b) Macrocyclic peptides selectively inhibit Pf20S over human c20S and i20S. Proteasome inhibitors are active against the Plasmodium parasites at multiple stages of their life cycle and are transmission blocking.